Jan Voorberg

Amsterdam, NH 1105AZ, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 134 publications

Closing in on ADAMTS13 conformation.

Closing in on ADAMTS13 conformation.

Journal: Journal of thrombosis and haemostasis : JTH
Published: April 08, 2026

Immunopeptidomics of blood coagulation factor IX: a core peptide derived from the protease domain is promiscuously presented on HLA-DR.

Immunopeptidomics of blood coagulation factor IX: a core peptide derived from the protease domain is promiscuously presented on HLA-DR.

Journal: Research and practice in thrombosis and haemostasis
Published: March 09, 2026

Cross-Reactivity of Antiphospholipid Antibodies with Gut Commensal Proteins in Antiphospholipid Syndrome.

Cross-Reactivity of Antiphospholipid Antibodies with Gut Commensal Proteins in Antiphospholipid Syndrome.

Journal: TH open : companion journal to thrombosis and haemostasis
Published: October 24, 2025

Allele-selective disruption of pathogenic VWF variants in type 2 von Willebrand disease using CRISPR/Cas9.

Allele-selective disruption of pathogenic VWF variants in type 2 von Willebrand disease using CRISPR/Cas9.

Journal: Blood advances
Published: October 15, 2025

Hemostatic and platelet proteins are associated with bleeding grade and time to major bleed in hemato-oncological patients.

Hemostatic and platelet proteins are associated with bleeding grade and time to major bleed in hemato-oncological patients.

Journal: Blood vessels, thrombosis & hemostasis
Published: October 07, 2025

Correction: Rewriting the script: gene therapy and genome editing for von Willebrand Disease.

Correction: Rewriting the script: gene therapy and genome editing for von Willebrand Disease.

Journal: Frontiers in genome editing
Published: October 06, 2025

Large deletions in the F8 gene predict immune tolerance induction failure in people with severe hemophilia A.

Large deletions in the F8 gene predict immune tolerance induction failure in people with severe hemophilia A.

Journal: Research and practice in thrombosis and haemostasis
Published: September 30, 2025

Unbiased plasma proteomics reveals hemolysis during ADAMTS13 relapse in patients with immune TTP.

Unbiased plasma proteomics reveals hemolysis during ADAMTS13 relapse in patients with immune TTP.

Journal: Blood advances
Published: September 26, 2025

A red blood cell-based antigen delivery system to facilitate T cell epitope presentation to promote peripheral tolerance to ADAMTS13 in immune-mediated thrombotic thrombocytopenic purpura.

A red blood cell-based antigen delivery system to facilitate T cell epitope presentation to promote peripheral tolerance to ADAMTS13 in immune-mediated thrombotic thrombocytopenic purpura.

Journal: Research and practice in thrombosis and haemostasis
Published: August 09, 2025

MHC class II presentation of FVIII-AnnexinA5 fusion proteins internalized by antigen presenting cells.

MHC class II presentation of FVIII-AnnexinA5 fusion proteins internalized by antigen presenting cells.

Journal: Frontiers in immunology
Published: July 17, 2025

Trp1250, Lys1252, and Arg1367 of ADAMTS13 comprise a hot spot for anti-CUB domain antibodies in patients with iTTP.

Trp1250, Lys1252, and Arg1367 of ADAMTS13 comprise a hot spot for anti-CUB domain antibodies in patients with iTTP.

Journal: Blood advances
Published: May 19, 2025

A comprehensive care pathway of gene therapy for hemophilia based on current guideline documents and summary of product characteristics: communication from the ISTH SSC working group on gene therapy.

A comprehensive care pathway of gene therapy for hemophilia based on current guideline documents and summary of product characteristics: communication from the ISTH SSC working group on gene therapy.

Journal: Journal of thrombosis and haemostasis : JTH
Published: May 09, 2025
Showing 1-12 of 134

Last Updated: 09/26/2026